Literature DB >> 27109609

Cerebral complement C1q activation in chronic Toxoplasma infection.

Jianchun Xiao1, Ye Li1, Kristin L Gressitt1, Helen He1, Geetha Kannan2, Tracey L Schultz3, Nadezhda Svezhova3, Vern B Carruthers3, Mikhail V Pletnikov4, Robert H Yolken1, Emily G Severance5.   

Abstract

Exposure to the neurotropic parasite, Toxoplasma gondii, causes significant brain and behavioral anomalies in humans and other mammals. Understanding the cellular mechanisms of T. gondii-generated brain pathologies would aid the advancement of novel strategies to reduce disease. Complement factor C1q is part of a classic immune pathway that functions peripherally to tag and remove infectious agents and cellular debris from circulation. In the developing and adult brain, C1q modifies neuronal architecture through synapse marking and pruning. T. gondii exposure and complement activation have both been implicated in the development of complex brain disorders such as schizophrenia. Thus, it seems logical that mechanistically, the physiological pathways associated with these two factors are connected. We employed a rodent model of chronic infection to investigate the extent to which cyst presence in the brain triggers activation of cerebral C1q. Compared to uninfected mice, cortical C1q was highly expressed at both the RNA and protein levels in infected animals bearing a high cyst burden. In these mice, C1q protein localized to cytoplasm, adjacent to GFAP-labeled astrocytes, near degenerating cysts, and in punctate patterns along processes. In summary, our results demonstrated an upregulation of cerebral C1q in response to latent T. gondii infection. Our data preliminarily suggest that this complement activity may aid in the clearance of this parasite from the CNS and in so doing, have consequences for the connectivity of neighboring cells and synapses.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glia; MAG1 antibodies; Neurons; Prefrontal cortex; Psychiatry; Toxoplasmosis

Mesh:

Substances:

Year:  2016        PMID: 27109609      PMCID: PMC5067173          DOI: 10.1016/j.bbi.2016.04.009

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  29 in total

Review 1.  Evasion of innate immunity by parasitic protozoa.

Authors:  David Sacks; Alan Sher
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 2.  Complement evasion by protozoa.

Authors:  S A Fuhrman; K A Joiner
Journal:  Exp Parasitol       Date:  1989-05       Impact factor: 2.011

3.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Meredith Halling; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Didier Dupont; Faith B Dickerson; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2012-07-16       Impact factor: 5.996

4.  Effects of toxoplasma on human behavior.

Authors:  Jaroslav Flegr
Journal:  Schizophr Bull       Date:  2007-01-11       Impact factor: 9.306

5.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

6.  Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells.

Authors:  Jianchun Xiao; Lorraine Jones-Brando; C Conover Talbot; Robert H Yolken
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

7.  Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.

Authors:  Jianchun Xiao; Stephen L Buka; Tyrone D Cannon; Yasuhiro Suzuki; Raphael P Viscidi; E Fuller Torrey; Robert H Yolken
Journal:  Microbes Infect       Date:  2009-07-26       Impact factor: 2.700

Review 8.  Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective.

Authors:  Geetha Kannan; Mikhail V Pletnikov
Journal:  Schizophr Bull       Date:  2012-09-01       Impact factor: 9.306

9.  The neurotropic parasite Toxoplasma gondii increases dopamine metabolism.

Authors:  Emese Prandovszky; Elizabeth Gaskell; Heather Martin; J P Dubey; Joanne P Webster; Glenn A McConkey
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

10.  Chitinase dependent control of protozoan cyst burden in the brain.

Authors:  J Philip Nance; Kevin M Vannella; Danielle Worth; Clément David; David Carter; Shahani Noor; Cedric Hubeau; Lori Fitz; Thomas E Lane; Thomas A Wynn; Emma H Wilson
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

View more
  22 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 2.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

3.  Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia.

Authors:  Ye Li; Emily G Severance; Raphael P Viscidi; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 4.  The microbiome, immunity, and schizophrenia and bipolar disorder.

Authors:  Faith Dickerson; Emily Severance; Robert Yolken
Journal:  Brain Behav Immun       Date:  2016-12-18       Impact factor: 7.217

5.  Chronic Toxoplasma gondii Infection Induces Anti-N-Methyl-d-Aspartate Receptor Autoantibodies and Associated Behavioral Changes and Neuropathology.

Authors:  Ye Li; Raphael P Viscidi; Geetha Kannan; Ross McFarland; Mikhail V Pletnikov; Emily G Severance; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

Review 6.  Schizophrenia and Infections: The Eyes Have It.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

7.  Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

Authors:  Yuichiro Itoh; Rhonda R Voskuhl
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

Review 8.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03

Review 9.  New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction.

Authors:  Naotaka Izuo; Atsumi Nitta
Journal:  J Pers Med       Date:  2021-05-03

Review 10.  The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.

Authors:  V L Nimgaonkar; K M Prasad; K V Chowdari; E G Severance; R H Yolken
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.